Project Grant K01ES036193

Award Date 4/16/24
Completion Date 3/31/27
Dollars Obligated $488K
Federal Grant Program
93.113
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90032, USA
Similar Awards
This $746,198 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on the relationship between per- and polyfluoroalkyl substances (PFAS) exposure and diabetic kidney disease (DKD) in youth with type 2 diabetes. The award will leverage data from two existing NIDDK-funded longitudinal cohort studies to assess how PFAS exposure...
This $121,057 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program supports a prospective study to investigate the associations between per- and polyfluoroalkyl substance (PFAS) mixtures and pregnancy outcomes, including spontaneous abortion, preterm birth, and small for gestational age births, among Black women. The study aims to describe the modifying role of perceived stress on these associations and...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to improve proteinuria testing and management after acute kidney injury (AKI). The $593,241 award, commencing on Jul 25, 2024, will fund a study led by Dr. Y. Diana Kwong, a nephrologist at the University of California, San Francisco (UCSF). The study will involve: 1) using semi-structured...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $168,886 to The University of Texas Southwestern Medical Center to conduct research on elucidating the role of NAD+ and PARP1 in nephron endowment and kidney development. The 5-year research project aims to study how maternal NAD+ availability and cellular compartmentalization impact...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is focused on determining the protective role of the transcription factor KLF2 in diabetic kidney disease (DKD) and developing KLF2 agonists as potential treatments. The total award amount is $2,202,378, with a performance period from September 20, 2024, to May 31, 2029. The key objectives of this...
This $478,503 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113) supports research to investigate the impact of prenatal exposure to per- and polyfluoroalkyl substances (PFAS) on the development of non-alcoholic fatty liver disease (NAFLD) in children. The award will leverage the existing GUSTO mother-child cohort in Singapore to conduct comprehensive assessments, including proton magnetic resonance...
This Project Grant award of $358,062 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to understand kidney endothelial maturity and mesenchymal transition in vascularized human kidney organoids. The research aims to: 1) examine whether kidney organoid co-culture enables the induction of kidney-specific endothelial maturation, and 2) determine if...
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) Federal Grant Program, will provide $709,575 to the University of Southern California to conduct a study on the impact of per- and polyfluoroalkyl substances (PFAS) on bone health in overweight/obese Latino populations across the life course. The study aims to determine the associations between plasma PFAS concentrations and measures of bone mineral density,...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support a large longitudinal cohort study to investigate the epidemiology and etiology of type 2 diabetes among Asian American, Native Hawaiian, and Pacific Islander adolescents and young adults. The $711,791 award to Kaiser Foundation Hospitals will enable researchers to leverage...
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) federal grant program provides $385,219 to the University of Rhode Island to study the role of albumin and other serum factors in the accumulation and toxicity of per- and polyfluoroalkyl substances (PFAS). The key objectives are to: Determine whether albumin is a key factor for PFAS distribution and elimination in mice. This will involve quantifying PFAS...

PFAS AND DIABETIC KIDNEY DISEASE IN YOUNG ONSET TYPE 2 DIABETES: EMERGING RISK FACTORS AND UNDERLYING MECHANISMS - PROJECT SUMMARY / ABSTRACT DIABETIC KIDNEY DISEASE (DKD) DEVELOPS IN MORE THAN 50% OF YOUTH WITH TYPE 2 DIABETES (T2D) AS THEY TRANSITION TO YOUNG ADULTHOOD. EARLY IDENTIFICATION OF YOUTH AT RISK OF DKD, EITHER DUE TO ENVIRONMENTAL OR BIOLOGICAL FACTORS, HAS THE POTENTIAL TO INFORM CLINICAL CARE AND ALTER THE COURSE OF DISEASE. DESPITE THE SUBSTANTIAL BURDEN OF DKD IN YOUTH WITH T2D, HOWEVER, MODIFIABLE RISK FACTORS AND EFFECTIVE THERAPIES REMAIN LIMITED. EMERGING EVIDENCE LINKS PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS), A GROUP OF UBIQUITOUS ARTIFICIAL CHEMICALS USED FOR MORE THAN 60 YEARS IN CONSUMER AND INDUSTRIAL PRODUCTS, WITH IMPAIRED KIDNEY FUNCTION, WORSE GLUCOSE REGULATION, AND HIGHER LEVELS OF UREMIC TOXINS, KEY RISK FACTORS FOR DKD IN YOUTH WITH T2D. THIS STUDY PROPOSES TO PERFORM THE FIRST PROSPECTIVE STUDY TO EXAMINE THE ASSOCIATION OF PFAS EXPOSURE WITH DKD RISK IN YOUTH WITH T2D AND TO INVESTIGATE POTENTIAL BIOLOGICAL MECHANISMS BY INTEGRATING KEY INFORMATION ON METABOLITES AND PROTEIN LEVELS. THE PROJECT WILL BUILD UPON EXISTING HEALTH AND OMICS DATA (METABOLOMICS AND PROTEOMICS) IN THE TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY) STUDY, A LONGITUDINAL STUDY OF YOUTH WITH T2D WHO UNDERWENT ANNUAL MEASURES OF KIDNEY FUNCTION FOR AN AVERAGE OF 10.2 YEARS. USING ARCHIVED PLASMA SAMPLES, THIS PROJECT WILL MEASURE LEVELS OF 10 COMMON PFAS AND UP TO 250 NOVEL AND EMERGING PFAS AT BASELINE. DUE TO THE LONG BIOLOGICAL HALF-LIVES OF MOST OF THESE CHEMICALS, SINGLE PFAS MEASURES ARE A GOOD PROXY FOR MEDIUM TO LONG-TERM PFAS EXPOSURES. ANALYSES WILL EXAMINE ASSOCIATIONS BETWEEN INDIVIDUAL PFAS AND PFAS MIXTURES WITH RISK AND PROGRESSION OF DKD USING SURVIVAL ANALYSIS AND MIXTURE METHODS. TO EXAMINE THE POTENTIAL BIOLOGICAL PATHWAYS THAT LINK PFAS EXPOSURE WITH DKD, ANALYSES WILL THEN EXAMINE ASSOCIATIONS OF PFAS (INDIVIDUAL AND MIXTURES) WITH METABOLITES AND PROTEINS POTENTIALLY ASSOCIATED WITH DKD RISK. FURTHER, A NOVEL LATENT UNKNOWN CLUSTERING APPROACH WILL BE APPLIED TO COMPREHENSIVELY ANALYZE PFAS EXPOSURE, MULTIOMICS, AND CLINICAL DATA TO IDENTIFY SUBGROUPS OF YOUTH WITH T2D AT HIGH RISK OF DKD. THESE RESEARCH FINDINGS WILL CONTRIBUTE TO THE BODY OF EVIDENCE NEEDED TO INFORM PFAS REGULATION AND DEVELOP INNOVATIVE ENVIRONMENTAL HEALTH INTERVENTIONS TO DETECT AND PREVENT DKD IN YOUTH WITH T2D. THE CULMINATION OF MY SCIENTIFIC TRAINING HAS PREPARED ME TO SUCCESSFULLY CARRY OUT THE PROPOSED K01 RESEARCH. THROUGH A MULTIFACETED TRAINING PLAN SUPPORTED BY A STRONG TRANSDISCIPLINARY MENTORING AND ADVISORY TEAM, THIS K01 WILL PROVIDE THE NECESSARY SUPPORT FOR ME TO FURTHER DEVELOP AS AN INDEPENDENT ENVIRONMENTAL HEALTH RESEARCHER. IN ADDITION TO THE PROPOSED RESEARCH PROJECT, A ROBUST YET ATTAINABLE TRAINING PLAN INCORPORATING DIDACTIC INSTRUCTION, SEMINARS, CONFERENCES, AND MENTORSHIP WILL PREPARE ME TO SUCCESSFULLY COMPLETE A FUTURE NIEHS R01 TO EXAMINE PERSONALIZED DKD PREVENTION STRATEGIES IN YOUNG INDIVIDUALS, WHEN POTENTIAL LESIONS MAY STILL BE REVERSIBLE, TO PROMOTE HEALTHIER LIVES IN THIS AT-RISK POPULATION.

Posted 4/15/24, 12:00 AM